50 related articles for article (PubMed ID: 26248024)
1. Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models.
Burley TA; Da Pieve C; Martins CD; Ciobota DM; Allott L; Oyen WJG; Harrington KJ; Smith G; Kramer-Marek G
J Nucl Med; 2019 Mar; 60(3):353-361. PubMed ID: 30213849
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative Tumor Assessment Using Real-Time Molecular Imaging in Head and Neck Cancer Patients.
van Keulen S; Nishio N; Fakurnejad S; van den Berg NS; Lu G; Birkeland A; Martin BA; Forouzanfar T; Colevas AD; Rosenthal EL
J Am Coll Surg; 2019 Dec; 229(6):560-567.e1. PubMed ID: 31568855
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy.
Sihver W; Pietzsch J; Krause M; Baumann M; Steinbach J; Pietzsch HJ
Pharmaceuticals (Basel); 2014 Mar; 7(3):311-38. PubMed ID: 24603603
[TBL] [Abstract][Full Text] [Related]
4. Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.
Pool M; de Boer HR; Hooge MNL; van Vugt MATM; de Vries EGE
Theranostics; 2017; 7(7):2111-2133. PubMed ID: 28638489
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.
Boeckx C; Blockx L; de Beeck KO; Limame R; Camp GV; Peeters M; Vermorken JB; Specenier P; Wouters A; Baay M; Lardon F
Am J Cancer Res; 2015; 5(6):1921-38. PubMed ID: 26269754
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression of EGFR and EMMPRIN in a series of cases of head and neck squamous cell carcinoma.
de Andrade AL; Ferreira SJ; Ferreira SM; Ribeiro CM; Freitas Rde A; Galvão HC
Pathol Res Pract; 2015 Oct; 211(10):776-81. PubMed ID: 26296920
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of nimotuzumab Fab
Bernhard W; Barreto K; Toledo D; El-Sayed A; Jett KA; Casaco A; Fonge H; Geyer CR
Sci Rep; 2023 Jul; 13(1):10990. PubMed ID: 37419997
[TBL] [Abstract][Full Text] [Related]
8. Advances in Development of Radiometal Labeled Amino Acid-Based Compounds for Cancer Imaging and Diagnostics.
Mikulová MB; Mikuš P
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33669938
[TBL] [Abstract][Full Text] [Related]
9. Novel genetic alterations and their impact on target therapy response in head and neck squamous cell carcinoma.
Jiang X; Ye J; Dong Z; Hu S; Xiao M
Cancer Manag Res; 2019; 11():1321-1336. PubMed ID: 30799957
[TBL] [Abstract][Full Text] [Related]
10. Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy.
Cordes N; Ney M; Beleites T; Aust D; Baretton G; Thames H; Baumann M; Krause M; Löck S; Appold S
PLoS One; 2018; 13(12):e0209479. PubMed ID: 30571736
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
[TBL] [Abstract][Full Text] [Related]
12. Current status and future perspectives of fluorescence-guided surgery for cancer.
DeLong JC; Hoffman RM; Bouvet M
Expert Rev Anticancer Ther; 2016; 16(1):71-81. PubMed ID: 26567611
[TBL] [Abstract][Full Text] [Related]
13. 111In-cetuximab-F(ab')2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts.
van Dijk LK; Hoeben BA; Stegeman H; Kaanders JH; Franssen GM; Boerman OC; Bussink J
Radiother Oncol; 2013 Sep; 108(3):484-8. PubMed ID: 23932156
[TBL] [Abstract][Full Text] [Related]
14. PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.
van Dijk LK; Yim CB; Franssen GM; Kaanders JH; Rajander J; Solin O; Grönroos TJ; Boerman OC; Bussink J
Contrast Media Mol Imaging; 2016; 11(1):65-70. PubMed ID: 26242487
[TBL] [Abstract][Full Text] [Related]
15. PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging.
van Dijk LK; Boerman OC; Kaanders JH; Bussink J
Clin Cancer Res; 2015 Aug; 21(16):3602-9. PubMed ID: 25931452
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor imaging in human head and neck cancer xenografts.
van Dijk LK; Boerman OC; Kaanders JH; Bussink J
Acta Oncol; 2015; 54(9):1263-7. PubMed ID: 26248024
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
